Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Forsteo
Hospital Authority, Hong Kong
Spine Deformity
1 trial -
Fosinopril
The First People's Hospital of Lianyungang
Chronic Kidney Disease
1 trial -
Freezor® Cardiac Cryoablation Catheter CryoConsole System
Rhythm Pharmaceuticals Netherlands B.V.
Tachycardia, Atrioventricular Nodal Reentry
1 trial -
Fremanezumab
Teva Pharma GmbH
Migraine
9 trials -
Fremanezumab Prefilled Syringe [Ajovy]
Teva Pharma GmbH
Migraine Disorders
1 trial -
Fruquintinib
Takeda
Colorectal Cancer
1 trial -
FuKe Qianjin Capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Endometritis
1 trial -
GAVRETO ®(pralsetinib) capsules
RIGEL PHARMACEUTICALS INC
Patients with advanced or metastatic solid tumors
1 trial -
GEICAM/2023-09
Ningbo Cancer Hospital
Early Breast Cancer
1 trial -
GR-2021-12373041
Verona Pharma Ireland Limited
patients with secondary progressive MS
1 trial -
GTM-103
GT Biopharma
Glioblastoma
1 trial -
GWP42003-P
Jazz Pharmaceuticals Ireland Limited
Lennox-Gastaut Syndrome
1 trial -
Gabapentin
United Therapeutics Europe Ltd
Peripheral Nerve Disorder Associated With Repair of Hernia
1 trial -
GadoCrohn
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Gadoterate meglumine
Guerbet
Hepatocellular Carcinoma
1 trial -
Gadoxetate disodium
Guerbet
Motor Function
1 trial -
Ganciclovir
Hoffmann-La Roche
Cytomegalovirus Infections
1 trial -
Gardasil 9 suspension for Evaluation of the reduction of…
The George Institute
Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV
1 trial -
Glatiramer Acetate
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
5 trials -
Glucagon-like peptide-1 receptor agonist:Semaglutide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Glycopyrronium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Nausea and Vomiting
1 trial -
Glycopyrronium in Combination With Tropisetron
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
Group 1 Standard of Care
Pacira Ireland Limited
Retraction of Colostomy
1 trial -
Group A (the standard 2HRZE/4HR regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
Group C : Saline + propofol group
Hospital Authority, Hong Kong
Urologic Surgery
1 trial -
Guanfacine hydrochloride (TAK-503)
Takeda
Attention Deficit Hyperactivity Disorder
1 trial -
Guilingji Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oligospermia
1 trial -
Guli capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Guselkumab
Janssen Cilag International NV
Arthritis, Psoriatic
3 trials -
H1N1 influenza A Vaccine (PANFLU.1)
Sinovac Research and Development Co.,
Influenza
1 trial -
HAC2018-001
H.A.C. Pharma
Neurogenic Orthostatic Hypotension
1 trial -
HCB.2021.1309
The George Institute
Coronary artery chronic total occlusion
1 trial -
HCV-001
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B Vaccines
1 trial -
HEBRO-001
The George Institute
Hypertension
1 trial -
HIPRA-HH-17
Hipra Human Health S.L.
COVID-19
1 trial -
HTX-011
Heron Therapeutics
Postoperative Pain
8 trials -
HTX-011
Heron Therapeutics
Analgesia
6 trials -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
HYQVIA
Takeda
Primary Immunodeficiency Diseases (PID)
2 trials -
Haloperidol
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Healive+Healive
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Healive® Lot 1
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Heliox inspirate
United Therapeutics Europe Ltd
Work of Breathing
1 trial -
Hemlibra 150 mg/mL solution for injection
Hoffmann-La Roche
Severe or Moderate Hemophilia A
1 trial -
Hemodialysis with Polymethylmethacrylate Artificial Kidney
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uremia
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.